The London-based pharmaceutical company said Japan's Ministry of Health, Labour and Welfare has accepted the application to review its Blenrep antibody drug in combination with BorDex or PomDex as ...
Blenrep is an antibody-drug conjugate comprising a humanised B-cell maturation antigen monoclonal antibody conjugated to the cytotoxic agent auristatin F via a non-cleavable linker. The drug linker ...
GlobalData on MSN6d
China grants BTD to Blenrep with BorDex for multiple myelomaThe BTD was granted based on the interim results of the Phase III DREAMM-7 trial, which met its primary endpoint.
A team of researchers has discovered an antibody that can counter all known variants of the COVID-19 virus. The scientists also claim the antibody can also resist distantly related viruses that ...
No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).
Antibody therapies are a type of biologic. They are typically monoclonal antibodies selected to bind to a particular protein (often a cell-surface protein), and produced using recombinant DNA ...
The London-based pharmaceutical company said Japan's Ministry of Health, Labour and Welfare has accepted the application to review its Blenrep antibody drug in combination with BorDex or PomDex as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback